Related Experiment Video
Updated: Jun 25, 2026
07:55
Pancreatic Tissue-Derived Extracellular Matrix Bioink for Printing 3D Cell-Laden Pancreatic Tissue Constructs
Published on: December 13, 2019
Pancreatic tissue engineering: towards a vascularized bioengineered cure for diabetes
Ji Ho Park1,2, Khadijat A Olawuyi1, Neekita R Jikaria1,2
1Irvin S. Zubar Plastic Surgery Research Laboratory, Department of Surgery, Penn State College of Medicine, Hershey, PA, United States.
Frontiers in Transplantation
|June 24, 2026
Summary
Tissue engineering aims to create pancreatic constructs for Type 1 diabetes, overcoming transplant limitations. Key challenges include vascularization and clinical translation for improved glucose regulation.
Area of Science:
- Biomedical Engineering
- Endocrinology
- Regenerative Medicine
Background:
- Type 1 diabetes involves autoimmune destruction of pancreatic beta-cells.
- Current pancreas and islet transplantation face donor scarcity and immunosuppression issues.
- Engineered pancreatic constructs offer a scalable alternative for insulin secretion.
Purpose of the Study:
- To review current strategies in pancreatic tissue engineering.
- To discuss challenges and future directions for engineered pancreatic constructs.
- To provide a translational overview from biology to clinical application.
Main Methods:
- Review of existing literature on pancreatic tissue engineering.
- Analysis of strategies for vascularization and immunoprotection.
- Evaluation of cell differentiation and translational progress.
Main Results:
- Insufficient vascularization is a major hurdle in engineered graft survival.
- Various strategies are being explored for creating functional, vascularized pancreatic constructs.
- Progress in animal and human trials highlights translational potential.
Conclusions:
- Pancreatic tissue engineering holds promise for Type 1 diabetes treatment.
- Addressing vascularization and clinical translation are critical for success.
- Further research and ethical considerations are needed for widespread application.
